Integrative Rare Disease Biomedical Profile based Network Supporting Drug Repurposing, a case study of Glioblastoma

BACKGROUND: Glioblastoma (GBM) is the most aggressive and common malignant primary brain tumor; however, treatment remains a significant challenge. This study aims to identify drug repurposing candidates for GBM by developing an integrative rare disease profile network containing heterogeneous types...

Descripción completa

Detalles Bibliográficos
Autores principales: McGowan, Erin, Sanjak, Jaleal, Mathé, Ewy A., Zhu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153381/
https://www.ncbi.nlm.nih.gov/pubmed/37131675
http://dx.doi.org/10.21203/rs.3.rs-2809689/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153381/
https://www.ncbi.nlm.nih.gov/pubmed/37131675
http://dx.doi.org/10.21203/rs.3.rs-2809689/v1

Ejemplares similares